Mpox No Longer Continental Public Health Emergency, Africa CDC Declares
The Africa Centers for Disease Control and Prevention (Africa CDC) declared Mpox is no longer a public health emergency of continental security.
The announcement on Friday comes almost a year and half after African Union’s public health agency declared its highest level of alert – the first time in the institution’s history – over the disease.
Africa CDC’s Director General Dr Jean Kaseya said the health emergency has officially been lifted following the recommendations from Africa CDC Emergency Consultative Group.
“Today marks a significant milestone in Africa’s collective journey toward strengthened health security,” Director General Dr Kaseya said, announcing the decision.
“This decision reflects Africa’s growing capacity to lead complex public health responses, grounded in strong political leadership, regional solidarity, and effective international partnerships,” he added.
Africa CDC exercised its expanded mandate under the revised 2022 statutes for the first time to declare the viral disease public health emergency alert in August 2024 after “a sharp escalation of Mpox transmission”, with 80,276 suspected cases and 1,340 deaths reported in that year.
The figures, according to the agency, represented more than a five-fold increase in cases and a two-fold jump in deaths compared with the same period in 2023, though DR Congo was bearing most of the burden, accounting for 96% of reported cases and 97% of deaths.
“In response, African leadership mobilized early and decisively,” Dr Kaseya said, with the High-Level Emergency Ministerial Meeting on Mpox held in Kinsashsa in April of that year “catalyzing political commitment and coordinated continental action.”
Africa CDC the response mobilized over 1 billion US dollars in financing, strengthened community-anchored surveillance through digitalized community health workers; expanded laboratory and genomic sequencing capacity more than ten-fold.
It also led to the deployment over 5 million Mpox vaccine doses across 16 countries; and advanced a unified research agenda engaging more than 2,000 African and global scientists.
“These efforts delivered measurable impact,” Dr Kaseya said. According to him, between peak transmission periods in early 2025 and late 2025, suspected cases declined by 40% and confirmed cases by 60%. The case fatality rate among suspected cases fell from 2.6% to 0.6%.
Africa CDC Chief warned the virus remained significant public health threat, saying:
“The lifting of the emergency status “does not mark the end of mpox in Africa. Rather, it signals a transition from emergency response to a sustained, country-led pathway toward elimination.
“Mpox remains endemic in several settings, and continued vigilance, targeted investment, and innovation will be essential to consolidate gains and prevent resurgence.”
The virus first detected in laboratory monkeys in 1958 – typically transmits through body fluids, respiratory droplets, and contaminated materials.”
The disease causes painful skin and mucosal lesions, often accompanied by fever, headache, muscle aches, back pain, fatigue, and swollen lymph nodes. Symptoms typically last for two to four weeks but may last longer in someone with a weakened immune system.

